US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

THEMES US R&D CHAMPIONS ETF

37.24

0.0000

Volume:- -

Turnover:- -

Market Cap:1.12M

PE:- -

High:37.24

Open:37.24

Low:37.24

Close:37.24

52wk High:39.83

52wk Low:30.96

Shares:30.00K

Float Shares:30.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:0.14

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Autonomix announces CIPO issued patent for catheter-based tech

Godavari Biorefineries Wins Mexican Patent for Antiviral Treatment Compounds

BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio

Nyrada Secures US Patent for Heart Protection Drug Candidate

MT Newswires Live

Liquidia shares plummet after court ruling on patent infringement claims

Liquidia says court ruled two of six ‘327 patent claims infringed by company

Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist

United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia

Judge upholds claims 1, 14 of United Therapeutics’ ‘327 patent

United Therapeutics up 13% to $543.85 following Liquidia patent ruling

Allarity updates on recent advances in Drug Response Predictor technology

Mayne Pharma Secures Long-Term IMVEXXY Patent Protection in U.S. Settlement With Sun Pharma

Fab-Form Seeks Global Patent for ZU 2XK Wall Aligner Ahead of 2027 Launch

Maravai Lifesciences’ TriLink BioTechnologies secures CleanCap China patent

FibroBiologics announces grant of European patent

Guangxi Launches Integrated "One-Stop" Intellectual Property Protection Service

Thalia Therapeutics Secures Chinese Patent for Lead AML Drug miRisten

Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041

MT Newswires Live

Changsha Expands Full-Chain Intellectual Property Protection System as 15 Departments Join Forces to Support Enterprises Going Global

Acadia Pharmaceuticals Gets US Patent Office Allowance for Trofinetide Dosing Patent

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/USRD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"USRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","market":"US","secType":"STK","nameCN":"THEMES US R&D CHAMPIONS ETF","latestPrice":37.237,"timestamp":1790971200000,"preClose":37.237,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":30000,"shares":30000,"eps":0,"marketStatus":"Closed","change":0,"latestTime":"10-02 16:00:00 EDT","open":37.237,"high":37.237,"low":37.237,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":37.237,"sharesOutstanding":30000,"nav":37.28,"aum":1118400,"dividendRate":0.003776,"bidAskSpread":0,"volumeRatio":0,"impliedVol":0.1087,"impliedVolPercentile":0.2019},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","floatShares":30000,"roa":"--","roe":"--","lyrEps":0,"shares":30000,"dividePrice":0.1406,"high":37.237,"amplitude":0,"preClose":37.237,"low":37.237,"week52Low":30.96,"pbRate":"--","week52High":39.83,"institutionHeld":0,"latestPrice":37.237,"eps":0,"divideRate":0.003776,"volume":0,"delay":0,"ttmEps":0,"open":37.237,"prevYearClose":33.9934,"prevWeekClose":37.237,"prevMonthClose":37.237,"prevQuarterClose":37.237,"fiveDayClose":37.237,"twentyDayClose":37.237,"sixtyDayClose":38.141},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/USRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-29","symbol":"USRD","reason":null,"defaultRemindTime":1785331800000,"announcedDate":"2026-07-28","type":"delisting","dateTimestamp":1785297600000},{"date":"2025-12-18","symbol":"USRD","amount":0.1402666,"announcedDate":"2025-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-18","defaultRemindTime":1766068200000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-18","currency":"USD","dateTimestamp":1766034000000,"payDate":"2025-12-19"},{"date":"2024-12-24","symbol":"USRD","amount":0.72425,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"USRD\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.72425,"currency":"USD"},{"executeDate":"2025-12-18","recordDate":"2025-12-18","paymentDate":"2025-12-19","value":0.1402666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"USRD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"USRD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672714805","title":"Autonomix announces CIPO issued patent for catheter-based tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714805","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714805?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:16","pubTimestamp":1790943393,"startTime":"0","endTime":"0","summary":"Autonomix (AMIX) Medical announced the Canadian Intellectual Property Office, CIPO, has issued Canadian Patent No. 3,183,802, titled, “Systems, Met...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-announces-cipo-issued-patent-for-catheter-based-tech-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-announces-cipo-issued-patent-for-catheter-based-tech-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","USRD","AMIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766791","title":"Godavari Biorefineries Wins Mexican Patent for Antiviral Treatment Compounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766791?lang=en_us&edition=fundamental","pubTime":"2026-10-02 12:32","pubTimestamp":1790915565,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Godavari Biorefineries Limited ( ($IN:GODAVARIB) ). Godavari Biorefineries Limited has secured a patent from th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/godavari-biorefineries-wins-mexican-patent-for-antiviral-treatment-compounds?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/godavari-biorefineries-wins-mexican-patent-for-antiviral-treatment-compounds?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751812","title":"BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751812","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751812?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":"Newly issued U.S. Patent and pending allowances in the U.S. and Mexico extend protection for the company's sterile placental allograft, micronized wound care, and umbilical cord extract technologiesPO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3372727/0/en/biostem-technologies-strengthens-placental-allograft-and-umbilical-tissue-patent-portfolio.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672780308","title":"Nyrada Secures US Patent for Heart Protection Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2672780308","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672780308?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:39","pubTimestamp":1790804385,"startTime":"0","endTime":"0","summary":"Nyrada  secured a US composition-of-matter patent for Xolatryp, strengthening intellectual property protection for the drug candidate's chemical structure against unauthorized manufacture, use, sale, or import, according to an Australian bourse filing on Wednesday after market hours.Xolatryp is being developed to protect the heart tissue from damage.The patent has a 20-year term from its September 2024 filing date and is part of the company's broader global patent strategy, with applications planned in key markets, including Australia, Europe, and Japan, the filing added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NYR.AU","USRD","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672781534","title":"Liquidia shares plummet after court ruling on patent infringement claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2672781534","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672781534?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:50","pubTimestamp":1790790613,"startTime":"0","endTime":"0","summary":"Shares of Liquidia (LQDA) were dropping following resumption of trade after the company confirmed the U.S. District Court for the District of Delaw...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-shares-plummet-after-court-ruling-on-patent-infringement-claims-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-shares-plummet-after-court-ruling-on-patent-infringement-claims-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","LQDA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672036789","title":"Liquidia says court ruled two of six ‘327 patent claims infringed by company","url":"https://stock-news.laohu8.com/highlight/detail?id=2672036789","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672036789?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:30","pubTimestamp":1790789431,"startTime":"0","endTime":"0","summary":"Liquidia (LQDA) issued an update regarding the litigation filed by United Therapeutics (UTHR) in the U.S. District Court for the District of Delawa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-says-court-ruled-two-of-six-327-patent-claims-infringed-by-company-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-says-court-ruled-two-of-six-327-patent-claims-infringed-by-company-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LQDA","USRD","BK4532","BK4139","BK4007","UTHR","LU1571399168.USD","LU1699723380.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672789452","title":"Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789452?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:10","pubTimestamp":1790788218,"startTime":"0","endTime":"0","summary":"Liquidia’s (LQDA) Yutrepia faces a Delaware court finding of infringement of United Therapeutics’ (UTHR) ‘327 patent, pressuring Liquidia shares bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-ruling-has-positive-read-through-for-mannkind-tyvaso-dpi-says-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-ruling-has-positive-read-through-for-mannkind-tyvaso-dpi-says-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LQDA","USRD","UTHR","MNKD","BK4532","BK4007","BK4139","LU1571399168.USD","LU1699723380.USD","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672789378","title":"United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789378?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:57","pubTimestamp":1790787420,"startTime":"0","endTime":"0","summary":"United Therapeutics notched a legal win in its patent lawsuit against Liquidia as a federal judge denied Liquidia's motion to block a portion of its legal claims.Liquidia had motioned to strike part of United Therapeutics' argument that relied on the \"common ownership exception,\" a rule in patent law preventing a new patent from being invalidated based on an earlier patent owned by the same entity. Judge Richard Andrews of the U.S. District Court for the District of Delaware on Wednesday denied Liquidia's motion.Shares of United Therapeutics were up 13% at $541.68 as of midday Wednesday. Liquidia shares fell 25% to $53.22.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1699723380.USD","USRD","UTHR","LQDA","BK4532","BK4139","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786174","title":"Judge upholds claims 1, 14 of United Therapeutics’ ‘327 patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786174","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786174?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:15","pubTimestamp":1790784928,"startTime":"0","endTime":"0","summary":"A judge has upheld claims 1 and 4 of United Therapeutics’ (UTHR) ‘327 patent, ruling that Liquidia (LQDA) has infringed on the patent. A final judg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/judge-upholds-claims-1-14-of-united-therapeutics-327-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/judge-upholds-claims-1-14-of-united-therapeutics-327-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1571399168.USD","LU1699723380.USD","BK4007","LQDA","BK4139","BK4532","UTHR","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786465","title":"United Therapeutics up 13% to $543.85 following Liquidia patent ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786465","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786465?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:15","pubTimestamp":1790784921,"startTime":"0","endTime":"0","summary":"12:11 EDT United Therapeutics (UTHR) up 13% to $543.85 following Liquidia (LQDA) patent ruling Published first on TheFly – the ultimate source for ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/united-therapeutics-up-13-to-543-85-following-liquidia-patent-ruling-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/united-therapeutics-up-13-to-543-85-following-liquidia-patent-ruling-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1699723380.USD","BK4139","BK4007","LU1571399168.USD","USRD","UTHR","BK4532","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207510","title":"Allarity updates on recent advances in Drug Response Predictor technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207510","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207510?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:10","pubTimestamp":1790773851,"startTime":"0","endTime":"0","summary":"Allarity (ALLR) Therapeutics provided an update on recent advances in its proprietary Drug Response Predictor technology, patent portfolio and in-h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allarity-updates-on-recent-advances-in-drug-response-predictor-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allarity-updates-on-recent-advances-in-drug-response-predictor-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLR","USRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671225700","title":"Mayne Pharma Secures Long-Term IMVEXXY Patent Protection in U.S. Settlement With Sun Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671225700","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671225700?lang=en_us&edition=fundamental","pubTime":"2026-09-30 08:23","pubTimestamp":1790727798,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group ( ($AU:MYX) ) just unveiled an announcement. Mayne Pharma has settled U.S. Paragraph IV patent litigation with Sun Pharmaceutica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mayne-pharma-secures-long-term-imvexxy-patent-protection-in-u-s-settlement-with-sun-pharma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mayne-pharma-secures-long-term-imvexxy-patent-protection-in-u-s-settlement-with-sun-pharma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","RND","NXTI","MEDX","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247738","title":"Fab-Form Seeks Global Patent for ZU 2XK Wall Aligner Ahead of 2027 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247738?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:42","pubTimestamp":1790714573,"startTime":"0","endTime":"0","summary":"The latest update is out from Fab-Form ( ($TSE:FBF) ). Fab-Form Industries has applied for a world patent on its ZU 2XK wall aligner and adjustable...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fab-form-seeks-global-patent-for-zu-2xk-wall-aligner-ahead-of-2027-launch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fab-form-seeks-global-patent-for-zu-2xk-wall-aligner-ahead-of-2027-launch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671242051","title":"Maravai Lifesciences’ TriLink BioTechnologies secures CleanCap China patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2671242051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671242051?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:05","pubTimestamp":1790712316,"startTime":"0","endTime":"0","summary":"The company states: “TriLink BioTechnologies announced it has been granted a new patent from the China National Intellectual Property Administratio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maravai-lifesciences-trilink-biotechnologies-secures-cleancap-china-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maravai-lifesciences-trilink-biotechnologies-secures-cleancap-china-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671214402","title":"FibroBiologics announces grant of European patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2671214402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671214402?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:36","pubTimestamp":1790685377,"startTime":"0","endTime":"0","summary":"FibroBiologics (FBLG) announced that the European Patent Office has granted European Patent No. 3568465, titled “Methods of Enhancing Fibroblast Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-announces-grant-of-european-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-announces-grant-of-european-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","BK4139","FBLG","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143852873","title":"Guangxi Launches Integrated \"One-Stop\" Intellectual Property Protection Service","url":"https://stock-news.laohu8.com/highlight/detail?id=1143852873","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143852873?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:00","pubTimestamp":1790665253,"startTime":"0","endTime":"0","summary":"The Guangxi Zhuang Autonomous Region Market Supervision Administration (Intellectual Property Office), in collaboration with the Regional Department of Justice and the Regional Data Bureau, has...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTNT","BK4139","LRND","WRND","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671296529","title":"Thalia Therapeutics Secures Chinese Patent for Lead AML Drug miRisten","url":"https://stock-news.laohu8.com/highlight/detail?id=2671296529","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671296529?lang=en_us&edition=fundamental","pubTime":"2026-09-29 14:30","pubTimestamp":1790663459,"startTime":"0","endTime":"0","summary":"N4 Pharma ( ($GB:THAT) ) just unveiled an update. Thalia Therapeutics has secured a new patent in China for its lead acute myeloid leukaemia drug c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/thalia-therapeutics-secures-chinese-patent-for-lead-aml-drug-miristen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/thalia-therapeutics-secures-chinese-patent-for-lead-aml-drug-miristen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBB","BK4007","BK4139","BK4539","USRD","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671261940","title":"Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2671261940","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671261940?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:25","pubTimestamp":1790645148,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  said partner Acadia Pharmaceuticals received a notice of allowance from the US Patent and Trademark Office for a new US patent covering weight-banded dosing of trofinetide, according to a Tuesday Australian bourse filing.The patent, once issued and with six months of pediatric exclusivity, is expected to extend US patent protection for trofinetide to March 28, 2041, nearly five years beyond the current protection period, the filing said.Trofinetide is marketed in the US under the brand names Daybue and Daybue Stix for patients aged two years and older with Rett syndrome, the filing added.The company's shares rose 2% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USRD","NEU.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167764599","title":"Changsha Expands Full-Chain Intellectual Property Protection System as 15 Departments Join Forces to Support Enterprises Going Global","url":"https://stock-news.laohu8.com/highlight/detail?id=1167764599","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167764599?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:11","pubTimestamp":1790637066,"startTime":"0","endTime":"0","summary":"Enterprises going global fear one thing most: their products sell well overseas, only to find their trademarks have been registered by someone else, or no sooner has their technology debuted than...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LRND","BK4139","PTNT","USRD","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671301268","title":"Acadia Pharmaceuticals Gets US Patent Office Allowance for Trofinetide Dosing Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2671301268","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671301268?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:17","pubTimestamp":1790630276,"startTime":"0","endTime":"0","summary":"Acadia Pharmaceuticals  said late Monday the US Patent and Trademark Office issued a notice of allowance for a patent application covering weight-banded dosing of trofinetide for the treatment of Rett syndrome.The company said the patent, if issued, is expected to provide US protection for trofinetide through March 28, 2041, including six months of pediatric exclusivity, extending protection by nearly five years.Trofinetide is marketed in the US as \"Daybue\" and \"Daybue Stix\" for the treatment of Rett syndrome in adults and children age 2 and older. The drug is also covered by a method-of-use patent that expires in July 2036, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USRD","LU2065171402.SGD","LU2065170008.USD","BK4139","ACAD","LU2065169927.USD","BK4080","LU2065171311.SGD","AKR","BK4231"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":190,"code":"91000000","status":"200"}]}}